In 2014, there was a surge in publications related to p53, meta-analysis, gastric adenocarcinoma and gastric cancer, which may indicate an increase in interest in the molecular genetic aspects of gastric cancer diagnostics. The gene discussed is TP53; the disease is gastric cancer.